Eli Lilly (LLY) is planning to advertise its blockbuster weight loss drug, Zepbound, for the first time next month. Despite investor and industry recognition of the branded GLP-1 drug, "unaided ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor ...

AP Health Writer (AP) — Eli Lilly is dialing back its 2024 forecast after underwhelming ... Advertisement Article continues below this ad The company brought in $3.1 billion in sales from Mounjaro and ...

Eli Lilly’s price-to-earnings (P/E ... When Apple changed iPhone privacy settings, Facebook’s ad revenue slowed. Instead of sugarcoating the situation, Zuckerberg came clean.

The drugmaker posted revenue of $11.44 billion in the period, also missing Street forecasts. Seven analysts surveyed by Zacks expected $12.03 billion. Lilly expects full-year earnings in the range of ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

The health technology assessment agency said that more evidence is needed on the clinical and cost-effectiveness of the drug Eli Lilly’s amyloid plaque-targeting Alzheimer’s disease (AD) drug has been ...

U.S. stock indexes edged lower after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company.

Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. The drugmaker Eli Lilly told the-then UK health secretary last year that its new Alzheimer’s drug ...

A new ad playing on TV, endorsed by Kaine, says he worked to lower insulin prices. We verify that claim before Election Day.